ABHAYRAB VACCINE PF

Abhayrab Vaccine PF is a purified, inactivated rabies vaccine widely used for both pre-exposure and post-exposure prophylaxis against rabies. It is an essential component of national immunization programs and is commonly included in hospital and clinic vaccination protocols to protect individuals at risk of rabies infection. This vaccine is supplied and administered under strict regulatory and clinical guidelines to ensure safety and efficacy.

The vaccine works by stimulating the immune system to produce protective antibodies against the rabies virus, helping prevent infection following exposure. Abhayrab Vaccine PF is suitable for use in individuals of various age groups, including those in high-risk professions or areas with a higher incidence of rabies. Its inactivated formulation ensures a safe and controlled immune response when administered according to recommended schedules.

The Abhayrab Vaccine PF must be administered exclusively by trained healthcare professionals, in accordance with national immunization guidelines and regulatory approvals. Proper dosing, administration, and adherence to clinical protocols are critical to achieving optimal protective outcomes, ensuring patient safety, and maintaining compliance with local and international vaccination standards.

Product Features

• Purified inactivated rabies vaccine
• PF (Preservative Free) formulation
• Suitable for pre- and post-exposure prophylaxis
• Injectable vaccine for hospital and clinic use
• Manufactured to meet vaccine quality standards
• Widely supplied to immunization programs and institutions

How It Helps

• Provides protection against rabies through pre- and post-exposure prophylaxis
• Stimulates the immune system to produce protective antibodies against the rabies virus
• Safe preservative-free formulation suitable for hospital and clinic administration
• Supports national immunization programs and high-risk patient protection protocols